Clinical Trial: A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07539415) titled 'A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers' on Feb. 09.

Brief Summary: Phase 1 Safety and Relative Bioavailability Study of DWRX5003 in Healthy Adults

Study Start Date: March 30

Study Type: INTERVENTIONAL

Condition: Obesity & Overweight Type 2 Diabetes

Intervention: DRUG: DWRX5003

Microneedle patch containing Semaglutide

DRUG: DWC202502

Semagluide

DRUG: DWC202503

Semaglutide

OTHER: DWRX5003P

placebo microneedle patch

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Daewoong Pharmaceutical Co. LTD.

Published by HT Digita...